1. Home
  2. MESO vs NBHC Comparison

MESO vs NBHC Comparison

Compare MESO & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$15.33

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$43.50

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
NBHC
Founded
2004
2009
Country
Australia
United States
Employees
81
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
MESO
NBHC
Price
$15.33
$43.50
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
N/A
$47.67
AVG Volume (30 Days)
286.3K
460.6K
Earning Date
02-26-2026
04-21-2026
Dividend Yield
N/A
3.03%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
N/A
$47,100,000.00
Revenue This Year
$629.74
$39.96
Revenue Next Year
$30.65
$7.14
P/E Ratio
N/A
$93.83
Revenue Growth
N/A
2.86
52 Week Low
$12.66
$35.06
52 Week High
$21.50
$47.28

Technical Indicators

Market Signals
Indicator
MESO
NBHC
Relative Strength Index (RSI) 47.68 45.69
Support Level $13.82 $40.68
Resistance Level $16.21 $44.12
Average True Range (ATR) 0.67 0.96
MACD -0.05 -0.27
Stochastic Oscillator 29.38 27.77

Price Performance

Historical Comparison
MESO
NBHC

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

Share on Social Networks: